Skip to main content
. 2016 Oct 27;2(4):369–379. doi: 10.3233/BLC-160075

Fig.1.

Fig.1

Potential circulating biomarkers. Potential circulating biomarkers for the management of bladder cancer including CTCs (circulating tumor cells) for enumeration and profiling, DNA, RNA, miRNA and protein (levels, metabolomics and spectrometry).